News
Recently, the results of China's Top 10 Pharmaceutical Biotechnology Advances in 2024 were announced in Xiamen. The P85-Ab Nasopharyngeal Cancer Early Diagnosis Kit—the EBV BNLF2b Antibody Detection Kit (Magnetic Microparticle Chemiluminescence), jointly developed by the Ningshao Xia’s team from Xiang An Biomedine Laboratory of Xiamen University, and WAITAl BioPharm, has been approved for mar...
On the afternoon of December 18, Zhao Junqiang, Deputy Director-General of the Department of Social Development at the National Development and Reform Commission (NDRC), and his delegation visited our institute to investigate the construction progress of the National Medical Research and Industry-Education Integration Innovation Platform (Vaccine R&D). The third grade researcher of Manpower Div...
Recently, the results of the 2024 "Huawei Cup" 21st China Graduate Student Mathematical Modeling Competition were announced, and our team was awarded the national second prize.The China Graduate Student Mathematical Modeling Competition is one of the themed competitions of the "China Graduate Student Innovation and Practice Series Competition," guided by the Department of Degree Management & Po...
On the morning of November 4, Shenglan Tang, Professor of Duke University School of Medicine and Director of the Global Health Research Center at Duke Kunshan University was invited to visit our school. NingShao Xia, Director of the National Key Laboratory of Infectious Disease Vaccine Research and Development and Academician of Chinese Academy of Engineering, President Jun Zhang, Vice Presiden...
Recently, the EBV BNLF2b Antibody Detection Kit (Magnetic Microparticle Chemiluminescence), jointly developed by Xiamen University and WAITAl BioPharm, has been approved for marketing by the National Medical Products Administration of China, with the registration certificate number 20243402134.In a previous report, Professor Xia Ningshao’s team in Xiang An Biomedine Laboratory of Xiamen Univer...
On the afternoon of August 28, 2024, a signing ceremony was held at Xiamen University’s Xiang’an campus for a cooperation agreement between the National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology (referred to as the “Key Laboratory”) and the Fujian Institute for Food and Drug Quality Control (FJIFDC). Attende...
AbstractHuman enteroviruses (HEV) can cause a range of diseases from mild to potentially life-threatening. Identification and genotyping of HEV are crucial for disease management. Existing typing methods, however, have inherent limitations. Developing alternative methods to detect HEV with more virus types, high accuracy, and sensitivity in an accessible manner presents a technological and anal...
![[Nature Communications] Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study](/virtual_attach_file.vsb?afc=5nNUCiUm6kozL8UQlQkn77snmLYnlrqfUmrkMz-sL8VRLmv0gihFp2hmCIa0USyPMkyPnkhRLzGPM46fL4A2LNliMm9aLRC8LmLPMl7YnlWFM77YL4CDnznFLNWRMR7Jqjfjo4OeosMaqVhTp1hXptQ0gY84gY84gtA8pUpcc&e=.jpg)
![[Nature Communications] A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus](/virtual_attach_file.vsb?afc=5M8QCknmM2LRQkMQNCDMlLZUmliLlMq2M4vsUzWRLRLbMlC0gihFp2hmCIa0MYysMYhkLkhVL4MVnlnkM7VVo7U4LN7bnzU4LR98nRCDMzrFUmCYnzC8M4fFLmlYnm9Jqjfjo4OeosMaqVhTp1hXptQ0gY84gY84gtA8pUpcc&e=.jpg)
